Literature DB >> 9398640

APP gene promoter constructs are preferentially expressed in the CNS and testis of transgenic mice.

N W Fox1, E M Johnstone, K E Ward, J Schrementi, S P Little.   

Abstract

Transgenic animals were used to examine the spatial and temporal regulation of the human beta amyloid precursor protein (APP) gene promoter region in vivo. A 2.9 kb DNA fragment encompassing the APP gene promoter was fused to the chloramphenical acetyltransferase (CAT) reporter gene (pAMY-CAT) or a partial cDNA encoding the potentially amyloidogenic C-terminal 100 amino acid region of APP (pAMY-C100). Expression of these transgenes occurred primarily, but not exclusively, in the central nervous system (CNS) and testis in multiple independent lineages of transgenic mice. Temporal expression of the CAT reporter gene during development paralleled that reported for the endogenous APP gene. These studies suggest that a CNS-responsive cis-acting element(s) may exist in the promoter/5'-flanking region of the APP gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398640     DOI: 10.1006/bbrc.1997.7728

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Differential effect of zinc finger deletions on the binding of CTCF to the promoter of the amyloid precursor protein gene.

Authors:  W W Quitschke; M J Taheny; L J Fochtmann; A A Vostrov
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

2.  Mice transgenic for a human amyloid precursor protein promoter-lacZ reporter construct.

Authors:  K L Wright; D G Morgan; X Yu; J R Goss; J M Salbaum; K Duff; M N Gordon
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

Review 3.  Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.

Authors:  Kumar Sambamurti; Nigel H Greig; Debomoy K Lahiri
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

4.  Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.

Authors:  Bao-Xi Qu; Qun Xiang; Liping Li; Stephen Albert Johnston; Linda S Hynan; Roger N Rosenberg
Journal:  J Neurol Sci       Date:  2007-06-15       Impact factor: 3.181

5.  Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice.

Authors:  Baoxi Qu; Philip J Boyer; Stephen Albert Johnston; Linda S Hynan; Roger N Rosenberg
Journal:  J Neurol Sci       Date:  2006-03-06       Impact factor: 3.181

6.  Mutant amyloid precursor protein differentially alters adipose biology under obesogenic and non-obesogenic conditions.

Authors:  Linnea R Freeman; Le Zhang; Kalavathi Dasuri; Sun-Ok Fernandez-Kim; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.